LSB Industries, Inc.
NYSE:LXUChemicals
-$0.50 today
- Market cap
- $689.07M
- Beta
- 0.32
- P/E (TTM)
- 17.8
- EPS (TTM)
- $0.63
Volume 1.03M
Average 1.41M
LXU EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
LSB Industries, Inc.NYSE: LXU
EBITDA · Q1 FY2026 · quarter ended Mar 2026
EBITDA grows, but more slowly than its trailing trend
Q1 FY2026 EBITDA of $45.59M rose 73.6% year over year, behind the +116.7% change in trailing-twelve-month EBITDA. Sequentially, it fell 8.6% from the prior quarter. Over 3 fiscal years it compounded at -27.4% a year.
Context
- EBITDA amounted to 23.6% of revenue in FY2025, up 7.8 pp from a year earlier.
- EBITDA increased in 1 of the last 3 fiscal years.
What to watch
Whether EBITDA reaches the consensus estimate from 3 analysts of $173.31M (+19.4%) for the fiscal year ending Dec 2026, a slowdown from the +75.5% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $45.59M-8.6% QoQ
- Last fiscal yearDec 2025
- $145.14M+75.5% YoY
- LTMMar 2026
- $164.47M+116.7% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +73.6% | +75.6% | +1.9 pp |
| 1 year | +75.5% | +19.4% | -56.1 pp |
| 3-year CAGR | -27.4% | +2.3% | +29.7 pp |
| 5-year CAGR | +0.8% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 145.14M USD
- Year-over-year change
- +75.5%
- 4-year CAGR
- -2.1%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 145.14M | +75.5% |
| FY2024 | 2024-12-31 | 82.69M | -42.6% |
| FY2023 | 2023-12-31 | 143.95M | -62.0% |
| FY2022 | 2022-12-31 | 378.6M | +139.1% |
| FY2021 | 2021-12-31 | 158.31M | — |
EBITDA vs competitors
How LXU compares with its peers on the latest reported figures
- LXU's LTM Mar 2026 EBITDA of $164.47M is the 3rd highest of the 11 companies compared; the peer median is $41M.
- Its year-over-year change of +116.7% is the 4th highest of 10, against a peer median of +0.9%.
- EBITDA amounts to 25.6% of revenue for LXU, versus a peer median of 11.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $466.81M | +8.6% | -1.5% | 37.8% | |
| LTM Mar 2026 | $252.23M | -2.0% | +4.9% | 13.4% | |
| LTM Mar 2026 | $164.47M | +116.7% | -27.4% | 25.6% | |
| LTM Mar 2026 | $139.17M | +482.9% | +34.4% | 33.4% | |
| LTM Mar 2026 | $95.71M | -48.1% | -21.8% | 6.2% | |
| LTM Mar 2026 | $66M | -84.7% | -57.7% | 2.3% | |
| LTM Mar 2026 | $15.99M | +128.8% | — | 9.2% | |
| LTM Mar 2026 | $9.72M | +364.3% | — | 49.5% | |
| LTM Mar 2026 | $9.53M | — | — | 9.6% | |
| LTM Mar 2026 | -$2.9M | -101.0% | -53.8% | 0.2% | |
| LTM Mar 2026 | -$19.76M | +0.9% | — | 8129.7% | |
| Peer median (excluding LXU) | $41M | +0.9% | -11.6% | 11.5% | |
Competitors are the stored peer set for LXU. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 556.24M | 901.71M | 593.71M | 522.4M | 615.21M |
| Cost of Revenue | 417.26M | 553.34M | 507.45M | 474.6M | 510.91M |
| Gross Profit | 138.98M | 348.37M | 86.26M | 47.8M | 104.3M |
| Gross Margin | 25.0% | 38.6% | 14.5% | 9.1% | 17.0% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 38.03M | 39.43M | 36.58M | 41.77M | 41.51M |
| Operating Expenses | 37.93M | 39.99M | 34.48M | 53.3M | 41.51M |
| Depreciation & Amortization | 69.94M | 68.02M | 68.92M | 74.28M | 81.93M |
| EBITDA | 158.31M | 378.6M | 143.95M | 82.69M | 145.14M |
| EBITDA Margin | 28.5% | 42.0% | 24.2% | 15.8% | 23.6% |
| Operating Income | 101.05M | 308.38M | 51.78M | (5.51M) | 62.8M |
| Operating Margin | 18.2% | 34.2% | 8.7% | -1.1% | 10.2% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 49.38M | 46.83M | 41.14M | 34.45M | 30.66M |
| Other Income / Expenses | (62.06M) | (38.86M) | (17.88M) | (20.53M) | (30.25M) |
| Income Before Tax | 38.99M | 269.52M | 33.9M | (26.04M) | 32.55M |
| Pre-Tax Margin | 7.0% | 29.9% | 5.7% | -5.0% | 5.3% |
| Income Tax Expense | (4.56M) | 39.17M | 5.97M | (6.68M) | 7.94M |
| Net Income | 43.55M | 230.35M | 27.92M | (19.35M) | 24.61M |
| Net Margin | 7.8% | 25.5% | 4.7% | -3.7% | 4.0% |
| EPS (Basic) | (4.40) | 2.72 | 0.37 | (0.27) | 0.34 |
| EPS (Diluted) | (4.40) | 2.68 | 0.37 | (0.27) | 0.34 |
| Weighted Avg Shares | 49.96M | 84.75M | 74.54M | 71.97M | 72.39M |
| Weighted Avg Shares (Diluted) | 49.96M | 86.03M | 75.1M | 71.97M | 72.39M |
LSB Industries, Inc.
NYSE:LXU
Intrinsic Alpha fair value
Locked
Current Price
$9.57
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.